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ABSTRACT%%Innovation!is!key!to!economic!growth.!But!firms,!across!sectors!and!regions,!are!highly!skewed!in! their! ability! to! engage! with! innovation,!and!even!more!skewed! in! their!ability! to! translate!investments! in! innovation! into! higher! growth.! While! there! was! initially! much! attention! on!
4("!!5 '"(:(;1due! to!the!assumption!that!they!are!more!entrepreneurial!and!innovative,!recent!evidence!that!small!firms!contribute!less!to!innovation!and!employment!than!commonly!believed,!has!caused!attention! to!move!towards!4'$,)##$+)+5'"(!(HGF).!There!is!however! the!risk! that! this! newly!emphasized! category!of! firms! is!also!being! 4.%*%5! given!













1.%Introduction%%Innovation! has! long! been! recognized! a!key!driver!of! economic!growth,!at!both! the!company!level! and! at! the! macroYeconomic! level! (Freeman! 1995;! Grossman! and! Helpman! 1991;!Verspagen,!2005).!This!has!caused! economists!and!policy!makers!to!spend!much!time!thinking!
$*),) #$ '"(,!! )"$()4##$+)+5!and!how!to!support!them,!both!directly!and! indirectly! (EC,! 2010;! OECD,! 2010).! Indeed,! across! sectors! and! regions,! firms! are! highly!skewed! in! their! ability! to! engage! with! innovation,! and! even!more! skewed! in! their!ability! to!translate!investments!in!innovation!into!higher!growth.!Thus!understanding!what!types!of!firms!are!most!important!for!generating!both!innovation!and!economic!growth!has!become!a!focus!of!both!innovation!policy!and!growth!policy.!Critically!however,!this!debate!has!developed!without!consideration! to!how! changes! in! the!external!environment!influence!the!performance!of!firms.!Our!contribution!is!to!investigate!when!different!factors!can!be!used!to!understand!high!growth,!specifically! by! investigating! the!effect!of! competition!on! the!relationship!between! innovation!and! growth.! In! so! doing! w (  4,#5 # 4,.5 '#(),# '"("))' $'growth!performance!(Nelson,!1991).!!!For!many!years! the!emphasis!has!been!on!the!role!that!small!firms!play!in!the!growth!process,!due! to! the! assumption! that! they!are!more! innovative!# 4#)'%'#*'!5! (Porter!1985;!Acs!and!Yeung!1999).!This!emphasis!builds!on! Schumpeter5('!.,$'  :1934)!where!he!focused!on!the!role!of!small!entrepreneurial!firms.!Indeed!many!national!and!transnational!policies!have!focused!on! filling! the! 4funding!gap5! faced!by!small! firms1,!precisely!due!to!the!assumption!that!filling! this! gap! will! lead! to! more! innovatio# # "%!$."#) $+' )" :'$" ) 5(
"!!#%$')#?FA?)$)*'$%#$""(($#5(	$'/$#@>@>%'$'";3!!Yet!recently!the!emphasis!on!small!firms!has!been!questioned!given!the!tiny!percentage!of!small!firms! that!contribute! to!new!jobs,!sales!and!innovation.!Shane!(2008)!has!shown!that!in!the!US!only!0.05%!of!new!firms!contributed!11%!of!sales!and!6%!of!jobs.!Kirchhoff!(1994)!found!that!10%! of! fastestYgrowing! firms! contributed! to! three!quarters!of!new! jobs!during!an!eightYyear!observation!period!within!a!cohort!of!firms!founded!in!the!US!in!1978.!In!the!UK,!Storey!(1994)!shows! that! only! 4%! of! new! firms! born! in! any! given! year!accounted! for!50%!of!all! the! jobs!created!by!surviving! firms!within!that!cohort!after!ten!years.!Likewise,!Bloom!and!Van!Reenan!(2006)! have! focused!on! low!productivity,!and! low! innovation!rates!of!most! small! companies!who!suffer!from!managerial!difficulties!and!are!less!prone!to!making!the!investments!needed!to!increase!productivity.!!!!Given! this! core! result! that! only! a! small! group! of! firms! generate! innovation,! productivity!increases!and! jobs,! different!studies!have!been!increasingly!emphasizing!not!firm!size!but!4high!growth5! firms! (Bartelsman!et!al,!2005;!Veugelers!and!Cincera,!2010;!Mason!and!Brown,!2013).!While!potential!high!growth!firms!are!often!4.$*#5'"(:	!),anger!et!al,!2013),!in!fact!high!growth! firms!are! found!of!all!sizes!(NESTA,!2009).!Shane!(2009)!has!argued!that!policy!should!focus! on! creating! high! quality! enterprises,! those! with! potential! for! high! growth,! rather! than!subsidizing! a!high!volume!of! small! firms!with!a! low! likelihood!of! success,!whether!success! is!measured! in! terms! of! innovation,! economic! growth,! or! jobs.! Using! quantile! regression!techniques! that!differentiate!high!growth! firms! (HGF)!from!low!growth!firms!(LGF),!Coad!and!
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-firms is not met by private agents, 
e.g. commercial banks. 
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Rao! (2008)! find! further!evidence! for! the! importance!of!high!growth! firms! in!one!of! the!most!studied! relationships,! the! relationship! between! spending!on! innovation! inputs! (e.g.!R&D)!and!growth.!They! find!that!R&D!and!patenting,!when!measured!as!a!composite!variable,!was!only!a!significant! predictor! of! growth! for! HGF;! for! other! firms! investing! in! R&D! and! innovation!appeared!to!be!only!a!cost.!In!the!face!of!such!evidence,!policy!makers!are!increasingly!trying!to!target!high!growth!innovative!companies!(EC!2020;!OECD!2012).!!
+# )( '#) ))#)$# )$ 4 '$,)5 '"(1 )he!paper! focuses!on!better!understanding!what!we!actually!know!about!them!!and!whether!there!is!the!danger!that!they!too!(like!SMEs!in!the! past)! are! becoming! a! fad! of! policy! makers,! with! little! evidence! to! justify! the! attention.!Indeed,! as! Delmar! et! al.! (2003)!note,!given! ))'$,) '"(' 4)"%$'!!.*#()!
%$%*!)$#5 :%3?FC;,! it! is! fundamental! to!understand! the!degree! to!which! the!HGF!category! is!capturing!something!structural,!that!can!indeed!be!targeted!by!policy!makers,!versus!a!transient!state,!dependent!on! idiosyncratic! features,! such!as! the!simple!fact!that!beginning!from!a!lower!position!will!enable!higher!growth.!!!We! focus! on! this! problem!by! looking!at!high!growth!and! low!growth! firms! in!one!particular!sector9the! pharmaceutical! industry9! and! ask! whether! a! key! relationship! which! industrial!economists!worry!about,!the!R&DYgrowth!relationship,!can!tell!us!anything!about!the!relevance!of!high!growth!firms.!Like!Coad!and!Rao!(2008)!we!use!quantile!regression!techniques!to!study!the!R&DYgrowth!relationship!for!high!growth!and!low!growth!firms,!but!by!focusing!on!only!one!industry!over!a! long! time! frame!(1963Y2002),!we!are!able!to!introduce!a!further!dimension!to!the!study:!changing!levels!of!competition.!!!!Indeed,! innovation! studies! have! found! that! classic! questions! concerning! the! relationship!between!variables! like!size!and! innovation,!and!industry!structure,!depend!on!the!phase!of!the!
#*()'.5( ()$'.3! For! example,! it! has! been! found! that! small! firms! tend! to! have! greater!advantage! in! periods! in! which! there! are! lower! scale! economies! and! more! market! share!instability! (Klepper,! 1997).! *( ()')# '$" .#" #( # # #*()'.5( ()$'.implies! abstracting! from! competitive! forces.! In! particular,! we! are! interested! in! whether!changing!market!structure,!and!the!degree!of!interYfirm!competition,!affects!the!degree!to!which!
4 '$,)5 '"( "))'3 iven! the! wellYknown! inverted! UYshape! relationship! between!innovation!and!market!structure!(Scherer,!1987;!Aghion!et!al.!2005),!and!the!understanding!we!
+$$,0 #)#().#($+'# #*()'.5( !Ycycle! (Gort!and!Klepper!1982),!the!question! is! whether! these! relationships! also! affect! the! importance! of!high!growth! firms,!and!what! insights! this!can!provide! to! the!recent! interest! that! such! firms!have!received.! And!given!that! firms! differ! so! much! in! their! growth! rates,! it! also! helps! us! to! answer! the! fundamental!question!posed!by!Nelson!(1991):!when!and!why!do!firm!differences!matter9a!subject!we!return!to!in!the!final!conclusion.!!!The!pharmaceutical!industry!is!a!particularly!interesting!industry!to!look!at!for!several!reasons.!First,!it!is!an!innovation!intensive!industry,!with!higher!than!average!R&D!spending.!It!is!also!an!industry! in! which! the! ability! of! R&D! to!generate!growth!has!been!questioned,!given! the! low!productivity! of! this! spending!when! looked!at! in! relation! to!new!medicines!coming!out!of! the!sector.! Second,! it! is! an! industry! in! which! the! characteristics! of! innovation! have! evolved!significantly!over! the!course!of!its!history.!The!BayhYDole!act!in!1980!(which!allowed!publicly!funded! research! to! be! patented)! increased! the! number! of! entrants! in! the! industry,! and! the!search! regime! itself!went! through!big!changes! (Demirel!and!Mazzucato,!2012).!The! latter!has!
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#('(+#$#'$"%'$$4'#$"('5)$$#$"$'4*('51due!to!the!advances!in!IT!and!genomics!(Gambardella,!1995).!These!changes!were!accompanied!by!changes! in! the! level!of! concentration,!but!also!in!the!level!of!market!share!instability!in!the!industry.!While!we!do!not!focus!on!causal!issues!(e.g.!why!a!lower!level!of!concentration!should!impact! the! R&DYgrowth! relationship),! the! changing! competitive! landscape! (number!of! firms,!concentration,! instability)! is! enough! to! allow! us! to! see! whether! changing! industry!structure!
)( )' )$, 4'$,) '"(5'!(in!their!R&DYgrowth!relationship)!from!their!low!growth!counterparts.!!!The!paper! is! structured!as! follows.!Section!2! reviews! the!recent! literature!on! three!key!areas!related! to! the!study.!Section!3! introduces! the!data!used! in! the!study,!why! the!pharmaceutical!industry! was! chosen,! and! presents! some! descriptive! statistics! and! figures! which! raise! some!initial!questions!about! the!usefulness!of! the!high!growth!firm!category.!Section!4!discusses!the!characteristics! of! the! competitive! environment! in! the! pharma! industry! that! are! used! to!determine! two! different! competition! regimes.! Section! 5! discusses! quantile! regression!techniques!used!to!study!the!relationship!between!R&D!and!performance.!Section!6!reports!the!quantile!estimates!and!Section!7!concludes!with!discussion!of!our!key!result:!high!growth!are!indeed!the!best!performing!(in!terms!of!the!R&DYgrowth!relationship)!but!this!only!holds!in!the!period!in!which!competition!is!fiercest,!and!variety!is!the!highest.!!!
2.%Innovation,%Firm%Size,%Growth,%and%Competition%%As!our!study!looks!at!the!R&DYgrowth!relationship,!for!high/low!growth!firms,!over!the!course!of! industry! history,! we! begin! by! reviewing! three! strands! of! literature! that! relate! to! this!objective.!The! first! is! the! literature!which! focuses!on! the!need! for! innovation!policy! to!target!SMEs! and/or! 4 '$,)5 '"(3  ($# ( ) !)')*' )) ( highlighted! the!problematic! aspects! of! the! R&DYgrowth! relationship.! And! the! third! is! the! literature! that! has!focused! on! the! changing! relationship! between! size,! growth! and! innovation! in! different!competitive!environments!and!how!those!environments!change!over!the!industry!lifeYcycle.!!
%
2.1.%R&D,%Innovation%and%Growth%%We! focus! on! the! R&DYgrowth! relationship!due! to! the! importance!of!R&D! in!national!policies!aimed! at! achieving! 4("')5 '$,) :uropean! Commission! 2010),! and! due! to! the! great!heterogeneity! in! the!ability!of! firms! to!achieve!growth! from!their!R&D!spending!(Demirel!and!Mazzucato!2012).! In! fact,! it!has!been!observed! that! returns! to!R&D!are!generally!at!a!45!year!low!(Lang,!2009)!with!R&D! investment!in!fast!growing!sectors!growth!outpacing!the!resultant!firm!growth!(Ejermo!et!al.!2011).!!!While!endogenous!growth!theory!(Grossman!and!Helpman!1991)!assumes!a!direct!relationship!between! R&D! and! growth! at! the! macroeconomic! level,! at! the! microeconomic! level! the!relationship! has! been! harder! to! find! (Verspagen,! 2005).! While! some! studies! find! a! positive!relationship!between!firm!spending!on!R&D!and!firm!growth!(Del!Monte!and!Papagni!2003),!of!course!others!have!found!either!no!significant!impact!(Almus!and!Nerlinger!1999)!or!sometimes!even!a!negative!impact!with!regards!to!employment!growth!(Brouwer!et!al.!1993).!This!creates!confusion! for! policy! makers! that! have! been! arguing! for! target! levels!of!R&D! spending!at! the!national!level!(e.g.!see!EC!2020,!European!Commission!2010).!!!The! core! issue!of! course! is! that!outcomes!of!R&D!spending!vary!dramatically!between! firms.!Even!among! firms!with!a!track!record!of!innovative!behavior!there!are!clear!differences!in!the!
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nature! of! internal! and! external! processes,! relationships,! capabilities! and! general! innovative!persistence!(Demirel!and!Mazzucato!2012).!One!variable!that!has!been!found!to!be!particularly!illuminating!is!the!degree!to!wh'"('#)'4%'(()#5$##$+)$#3Geroski!et!al.!(1997)!have!shown!that!persistence!of!innovation!is!quite!rare;!firms!struggle!to!be!innovative!for!sustained!periods,!yet!those!that!can!achieve!a!level!of!persistence!are!often!responsible!for!the!majority!of!innovations.!Cefis!and!Orsenigo!(2001)!find!that!persistence!is!more!common!in!Schumpeter! type! 1! sectors! that! have! higher! barriers! to! entry! (as! opposed! to! Schumpeter! 2!sectors!with! lower!barriers,!and!more!instability).!Demirel!and!Mazzucato!(2012)!find!that!the!R&D!growth!relationship!in!pharmaceuticals!(a!Schumpeter!1!industry,!science!based!with!high!barriers)!is!indeed!strongest! for!firms!that!have!patented!persistently.!!!Studies!have!also!found!that!access!to!venture!capital!is!important!in!determining!the!degree!to!which! R&D! spending! by! firms! leads! to! better! economic! performance! (Gompers! and! Lerner!2001).!This! is!not! surprising!given! that! the!high!uncertainty!associated!with!innovation!means!that! access! to! risk! capital! is! fundamental.! But! how! do! VC! investors! decide! which! firms! to!provide! risk! capital! to?! Recent! literature! has! pointed! to! their! attention! to! patenting! and! a!lookout!for!high!growth!4/!!5).%')'()(!(Baum!and!Silverman!2004).!It!follows!that!high!growth! firms!are!expected! to!have!better!access! to!venture!capital! (Gompers!and!Lerner!2001).! VC! investors! are! also! expected! to! have! expertise! in! the! identification! of! firms! with!disruptive!potential,! as! they!also!profit! from!the!success!of!funded!firms,!and!are!able!to!offer!expertise! to!help! firm!succeed!and!manage! the!difficulties!of!high!growth!development!(Baum!and!Silverman!2004).!High!growth!innovative!firms!should!potentially!grow!faster!with!venture!capital! support,! as!it!reduces!financial!and!managerial!constraints.!For!these!reasons,!below!we!use!a!VC!related!variable!as!a!control.!!!Our!work!builds!most!closely!on!the!literature!which!acknowledges!that!the!impact!of!R&D!and!innovation! on! growth! is! indeed! different! for! different! types! of! firms,! i.e.! slow! growing/fast!growing;!aboveYaverage!R&D!intensity/belowYaverage!R&D!intensity,!low!tech/high!tech!(Coad!and!Rao!2008;!Brouwer!et!al.!1993,!and!Del!Monte!and!Papagni!2003).!To!help!contribute!to!the!debate! regarding! the! relationship! between! high! growth,! SME! and!R&D,!we!also! focus!on! the!importance!of!R&D!scale,!in!addition!to!R&D!intensity.!!!
2.2.%Innovation,%size%and%high%growth%firms%%Our!study!contributes! to! the!understanding!of!high!growth!firms!by!looking!at!a!range!of!firm!specific!and!industry!specific!conditions!that!must!be!in!place!for!the!high!growth!category!to!be!meaningful.!We!int'%'))(4"##*!#((5,)'(%))$(%'!)$#(%))(+'.important!to!policy!makers:!the!relationship!between!R&D!and!growth!discussed!above.!!!Innovation! policy! has! long! targeted!small! firms,!due! to! the!assumption! that! smaller! firms!are!
"$' ,!!# )$ !!# ) ())*( &*$1 #"$' 4#)'%'#*'!5 # ##$+)+ :Porter!1985;! Acs! and! Yeung! 1999;3 ( ((*"%)$# ( )( '$$)( # *"%)'5( '!. ,$' (Schumpeter,!1934)! in!which!he!argued!that!it!was!the!entrepreneur!who!was!the!key!force!of!capitalism.!Of!course!the!SME!category!is!not!homogenous,!including!hiYtech!and!lowYtech!firms!(Nunes!et!al.!2012);!firms!with!different!attitudes!to!risk!taking!(Qian!and!Lee!2003),!and!firms!that! are! not! particularly! innovative,!yet!often!require!higher!profit!margins.! Indeed,! the!NeoY
*"%)'# !)')*'( ) #"$'(*)!%%'$1( #4*#',)$#)$#(5'large!or!small!firms!more!innovative.!Acs!and!Audretsch!(1990)!found!that!small!firms!are!most!innovative! in! industries! that! are! less! capital! intensive! and! in! industries! where! innovation! is!
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mainly! product! not! process! oriented.! Others! still! have! focused! on! the! degree! to! which!innovation! small/large! firms! are! better! at! competence! destroying/enhancing! innovations!(Christensen,! 1997).! Regardless! of! these! studies!which!qualify! the! importance!of! small! firms,!based! on! firmYspecific,! technology! specific! and! industry! specific! variables,! many! countries!continue! to!indistinctively!target!small!firms!in!the!hope!that!this!will!stimulate!innovation!and!growth.! Indeed,! Hughes! finds! that! the! UK!government!spends!£8!billion/year!on!small! firms,!more!than!on!the!police!force,!and!close!to!what!it!spends!on!universities!(Hughes,!2008).! !!More!recently,!different!studies!have!argued! that! the! focus!on!small! firms!is!misplaced!given!their! low!productivity! (Bloom!and!Van!Reenan,!2006),! low! innovation!rates! (NESTA,!2009),!and! low! job! creation! (Storey,! 1994).! Kirchhoff! (1994)! finds! that! only! the! 10%! of! fastestYgrowing! firms! contributed! to! three! quarters! of! new! jobs! during! an! eightYyear! observation!period!within!a!cohort!of! firms!started! in! the!US! in!1978.!Haltiwanger!et!al.!(2013)!find!that!there! is! indeed!no!systematic! relationship!between!firm!size!and!growth.!Most!of!the!effect!is!from!age:!young! firms!(and!business!startYups)!contribute!substantially!to!both!gross!and!net!job!creation.!!!
(')&*(+*( )))#)$# )$"$+ '$"("!! '"(1 )$.$*# '"(#4
'$,)5 '"(3$"+ $*($# )'$!$ 4/!!(5!understood! to!be!young!innovative!firms!(Veugelers!and!Cincera,!2010).!Yet!Acs!et!al.!(2008)!find!that!it!is!older!firms,!on!average!25! years! old,! that! demonstrate! both! high! employment! and! high! sales! growth.! Indeed,! more!recent! focus!has!been!on!a!categor.$'"(!!4'$,)5'"(3((*()'(increasing!evidence! that! is!a! small!percentage!of! firms! that!achieve!high!growth,!but!also!that!these! firms!are! likely! to!be!mature!and!relatively!large!(Audretsch,!2012).!In!the!UK,!NESTA,!a!think! tank,!has!published!a!series!of! influential! reports,!arguing! that!between!2002!and!2008,!most! of! the! employment! generation! in! the! UK! was! due! to! high! growth! firms! across! a! wide!variety! of! sectors! (high! and! low! tech)! (NESTA! 2009)! and! that! in! the!postYcrisis!period!high!growth! businesses! accounted! for! a! disproportionate! amount! of! job! growth! (NESTA! 2011).!These!reports!have!basis! in! the! literature,!and!relate!to!studies!including!Coad!and!Rao!(2008)!and!Hölzl!(2009)!which!find!that!often!only!the!fastest!growing!firm!reap!any!benefit!from!their!innovation! (proxied!by!an! indicator! that!combines!both!R&D!and!patents)!in!terms!of!sales!or!employment!growth.!Relatedly,!Colombelli!et!al.!(2012)!find!evidence!that!HGF!are!key!actors!in!the! creation! of! new! knowledge,! indicating! some! support! for! the! relationship! between!innovation!and!HGF.!!!However,!some!recent!work!casts!doubt!on!the!relationship!between!innovation!and!HGFs.!!!!For!example,!Henrekson!and!Johansson!(2010)!find!that!technology!firms!are!underYrepresented!in!the! population! of! HGF;! they! find! HGF! in! all! industries,! but! particularly! in! service! based!industries.! Other! studies! have! found! innovative! high! growth! firms! lack! significant! levels! of!investment! in! R&D! (Mason! and! Brown,! 2013),! or! find! evidence! of! a! negative! relationship!between! innovation! and! growth! (Freel! and! Robson,! 2004).! However,! Stam! and! Wennberg!(2009)! in! their! study!of!new! firms!offer!some!support! that!R&D!does!matter! to! firm!growth,!including! HGFs,! but! only! applies! to! a! select! group! of! new! and! hiYtech! firms.! They! find! no!relationship!between!R&D!and!growth!for!the!majority!of!new!firms!in!their!study.!!!Some! of! the! complexities! of! understanding! growth! are! expected! to! lie! in! both! the! use! and!measurement! of! the! term! growth.! Delmar! et! al.! (2003; '$#/ 4 '$,)5 ( 
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heterogeneous! phenomenon,! multidimensional! in!nature,! such! that!different!measures!of!high!growth!are!not!necessarily! related.!They!propose! that!studies!using!single!measures!of!growth!must! be! careful! to! ensure! their! measure! reflects! the! theoretical! perspectives! applied,! and!propose! that! other! more! complex! multidimensional! or! composite! measures! of! growth!may!capture!the!complexities!of!the!growth!phenomenon.!
%A! feature!common!to!studies!of!R&D!and!growth!is!a!failure!to!account!for!changes!in!industry!market! structure! over! time.! If! policy! is! to! successfully! stimulate! the! innovationYgrowth!relationship,! we! argue! policy! must! be! sensitive! to! the! wider! dynamics! of! industry,! and!specifically! the!competitive!environment.!This! is!the!focus!of!the!final!section!of!our!literature!review.! Evaluating! how! the! determinants! of! growth! vary! with! industry! structure! during!different! time! periods! helps! us! answer! an! important! question:! does! variety! always! matter!(Nelson,!1991)?!!!
2.3%Competition%and%Innovation%over%	
		
%%A!corollary!of!Schumpeter5($#'#,))'!)$#(%),#(/###$+)$#,((concern! for! the! relationship! between! industry! structure! and! concentration.! In! situations! in!which! small! firms! are! more! innovative,! industry! structure! will! tend! to!be! less!concentrated.!Studies! which! have! tested! this! proposition! have! found! that! there! is! an! inverted! U! shape!relationship!between! innovation!and!concentration! (Scherer!and!Ross,!1990):!modest!degrees!of! concentration!are!the!ones!which!foster!the!most!spending!on!R&D.!The!reason!is!that!when!there! is! too! much! competition,! there! is! low! ability! to! appropriate! innovation! hence! little!incentive!to!spend!on!it.!And!when!there!is!too!much!concentration!firms!become!more!inertial!and!can!also!protect!their!market!power!without!feeling!the!pressure!to!innovate!(Aghion!et!al.!2005).!The!latter!effect!is!strongly!related!to!the!role!of!patents!in!allowing!firms!to!appropriate!the!returns! from!new!knowledge!(Arrow,!1962).!!!A! further! important! area! of! study! in! this! vein! is!how! industry!structure,!and! its! relationship!with! innovation,! changes! over! time,! as! an! industry! matures.! 4+$!*)$#'.5 ()'#$ )Schumpeterian! literature!has! indeed! focused!much!on! the! role!$'#) ).%($4(!)$#5pressures!over!time,!which!winnow!in!on!the!variety!that!is!created!in!the!process!of!interYfirm!competition! (Nelson! and!Winter,! 1982).! Industry! lifeYcycle! studies,! wi)# ) 4+$!*)$#'.5tradition,! have! shown! that! the! relationship! between! R&D!spending!and! firm!growth!changes!over! time! (Klepper,! 1997).! In! the! early! stage,! when! R&D! spending! tends! to! focus! more! on!
4%'$*)5##$+)$#,!entry!rates!are!high!as!is!also!market!share!instability.!Only!once!a!certain!
%'$*) 4()#'5 (()!(1$(0)#)$$*("$'$#%'$((##$+)$#1,(also!more!susceptible!to!dynamic!increasing!returns!to!scale!that!favor!large!firms.!This!process!of! dynamic! increasing! returns! tends! to! lead! to! more! concentrated! markets! and! less! market!share! instability.!Mazzucato! (2002)!has!shown!how! in!reality! this!evolution! is!more!complex,!with! some! industries! following! this! pattern! in! a! classic! form! (e.g.! autos),! while! others!experience! more! instability! in! the! later! part! of! their! lifeYcycle! (e.g.! personal! computers)!depending!on!)4%$,'5$#,#)'#)()$!!#)status!quo.!This!was!the!case!for!the!PC! industry!when! the! IntelYPlatform!replaced! the! IBM!platform! in!1990,!allowing! those!firms!that!had!already!entered!to!finally!innovate!outside!the!IBMYcompatible!boundaries.!!!In!our!study!we! focus!on! the!dynamics,! rather!than!on!causal!relationships.!That!is,!we!do!not!ask! what! the! effect! of! concentration! is! on! the! difference! between! the! performance! of! high!growth! and! low! growth! firms;! we! simply! ask! whether! it! is! different.! We! of! course! do!
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hypothesize!about! this! in!the!discussion,!but!it!is!not!something!we!test!for.!We!note!the!major!changes!that!occurred!in!the!industry!(e.g.!the!BayhYDole!act!which!allowed!new!firms!to!enter),!and! 4"(*'5 $"%))$#*(#'#) #)$'(1#(,)' ) "%$')#$growth! firms!differs! in!different!competitive!environments!as!measured!by!those!indicators9regardless!of! the!reasons!which!we!cannot!study!causally! in! this!particular!study.!We!choose!both! classic! measures! of! competition,! e.g.! industry! concentration,! as! well! as! more! dynamic!indicators,! e.g.!market!share! instability! (Hymer!and!Pashigian,!1962).! Indeed! this! latter!proxy!we! believe! is! especially! important! because! even! with! a! constant! level! of! concentration,!increasing!competitive!pressures!will! force! firms! to!differentiate! themselves,!even! if!this!does!not!affect! the!number!of! firms! it!may!affect! their!market!shares.!And!it!is!market!share!that!is!the!key!concern!of!competing!firms.!!!
3.%Data%and%descriptive%analysis%We! focus! on! one! industry! so! to!be!able! to! study! the!effect!of!R&D!on!growth,!as! innovation!dynamics!and!competition!unfold.!In!particular!we!select!pharma!as!an!opportunity!to!study!the!long!term!dynamics!of!an!industry!where!R&D!and!innovation!have!historically!played!a!critical!role! in! determining! the! success! of! firms,! as! a! result! of! translating! pioneering! R&D! in! drug!discovery!and! first!mover!advantages!into!significant!financial!reward!(Grabowski!and!Vernon!1987;!Dosi!and!Mazzucato!2006).!However,! since! the! late!1990s! the!productivity!of!R&D!has!fallen!(Paul!et!al.!2010),!and!firms!have!struggled!to!produce!blockbuster!products,!resulting!in!a!rising!cost!for!each!new!molecular!entity!(NME)!approved!(Scannell!et!al.!2012).!The!evolution!of! the! pharmaceutical! industry! has! received! significant! scholarly! attention,! documenting! the!changing! nature! of! competition! as! a! result! of! new! innovation,! and! regulatory! changes!(Gambardella!1995;!Orsenigo!et!al.!2001),!and!so!makes!an!ideal!industry!for!our!analysis!that!seeks! understand! the! relationship! between! R&D! and! growth! under! different! competitive!regimes.!This!allows!us!to!when!high!growth!matters!more.!We!begin!by!looking!at!high!growth!firms! using! descriptive! statistics! which! later! help! us! to! interpret! the! regression! results!with!respect!to!the!literature!identified!in!Section!2.!!
%
3.1%Data%%Our! dataset! includes! observations! on! pharmaceutical! firms! (GICS! 352020)! tracked! by!COMPUSTAT! related! to! the! financial!years!1950Y2007.!The!COMPUSTAT!database!covers! the!entry!and!exit!of!pharma!firms!trading!on!North!American!stock!exchanges!since!1950,!covering!a! total!of!370! firms.!From!this!database!we!collect! information!on!annual! investment!in!R&D,!sales,!assets!and!acquisition!values.!Firms!with!observations!relating!to!a!broken!time!series!are!cleaned,! so! that!only! the! longest! spell! is!considered,!resulting!in!observations!on!303!firms.!All!financial!data!is!deflated!to1982Y84!level.!!!Our!dataset!includes!the!major!pharmaceutical!players!with!worldwide!sales,!plus!US!and!major!nonYUS! firms.! COM5( !()# $ %'" '"( '$' )$)! (!($=BF@# #@>>D1accounting! for!approximately!77%!of!world!pharmaceutical! sales!activity2.!COMPUSTAT!data!provides! a! good! representation! of! the! global! pharmaceutical! industry,! including! firms! with!headquarters! in!US!and!Europe!as!well! in!more!recently!firms!in!developing!countries!such!as!India!and!China.!!!




Our! data! reveals! a! striking! feature! of! the! pharmaceutical! industry,! in!contrast! to! its!popular!image!as!formed!entirely!of!large!MNC,!which!is!a!significant!presence!of!SMEs.!The!composition!of! SME! (defined! as! less! than! 500! employees)! in! the!sample! increases!overtime,! from!zero! in!1963,! to!37%! in!1980,! rising! to!a!maximum!of!63%! in!1996.!The!presence!of! such!number!of!SMEs! in! the! latter!stages!of! the!pharmaceutical! industry! lifecycle! is!both!a!distinctive! feature!and!relevant!given!our!focus!on!high!growth!literature!as!described!in!Section!2.!!Merger! and! acquisition! activity! is! also! a! feature! of! the! pharmaceutical! industry,! and!COMPUSTAT! records! firm! annual! expenditure! on!acquisition!activity.!However!COMPUSTAT!does! not! report! accounting! information! to!determine! the! long! term!performance!of!acquired!firms!or! subsidiaries,! so! it! is!not!possible! to! report!statistics!on!long!term!organic!vs.!acquired!growth.!!!In! cases!when!a! firm!recorded! in! the!COMPUSTAT!database! is!acquired,! the!historical!annual!observations!of!the!target!firm!are!recorded,!but!target!firm!activity!postYacquisition!is!recorded!with! that!of! the!parent! firm.! In!a!minority!of! cases!where! it! is!deemed! that!at!least!two!firms!have!merged! to!create!a!new!entity,! such!as! in! the!case!of!Hoechst!Marion!Roussel!and!Rhone!Poulenc!Rorer! to!create!Aventis,! the!historical! records!of!each!merging!firm!are!maintained!in!COMPUSTAT!to!the!point!of!merger,!and!a!new!company!entry!records!postYmerger!activity.!!!From! extensive! searches! of! Who! Owns!Whom,! LexisNexis! International,!	$$+'5( $"%#.Profiles,!Bloomberg!Business!Week!profiles,!and!Edgar!SEC!filings,!it!was!possible!to!identify!a!total!of!83! firms!exiting! the!dataset!as!a!result!of!M&A!activity!during!the!period!1950!to!2008!although! all! occurred! post! 1980.! Of! the! total! acquisition! targets! recorded! in! our! sample,!61!could!be! traced! to!a!parent! firm!also! listed!in!our!sample!data.!As!a!result!we!can!record!firmYyears!where!reported!sales,!and!sales!growth!and!other!firm!measures,!will!likely!to!have!been!directly! influenced!by!acquisition!activity!of! competing!pharma.!This!does!not!account!for!all!M&A!activity,!as!pharma! in!recent!decades!has!relied!increasingly!on!acquisition!of!small!firms!to!support!their!pipeline!which!may!have!long!term!performance!implications.!However,!it!does!include! major! acquisitions! likely! to! have! a! transforming! shortYterm! influence!on!big!pharma!accounts3.!!!Using! the! list! of! COMPUSTAT! pharma! firms!as!a!base!population!we!merge! the!NBER!patent!database! (Hall! et! al.! 2001)! and! Thomson! Private! Equity! database.! The! patent! data! from!the!NBER!project!and!subsequent!updates!for!2002!and!2006!were!used!to!provide!information!on!patent!counts!for!each!COMPUSTAT!listed!firm,!allocating!patents!according!to!ownership!at!the!point! of! application! (Hall! et! al.! 2001).! The! coverage! of! the!NBER!dataset! is! from!1962!until!2008,! thus! we! do! not! have! reliable!patent!data! for! the!period!1950! to!1962.!Secondly!as!we!count!firms!with!granted!patent!status,!because!of!the!lag!between!patent!application!and!grant,!applications! made! in!periods! from!2003!onwards!show!a! lower!grant! rate! in! the!database,!as!when! the! dataset! was! compiled! there! were! still! being! reviewed.! Therefore! we! take! a!conservative!approach!and!use!patents!applied!for!between!1962!and!2002.!!!The!names!of!pharma! firms! in!COMPUSTAT!were!cross! referenced!with!the!Thomson!Private!Equity! database! recording! the! amount! and! year! of! investment! for! those! firms! that! received!
                                                 
3 We make use of both the COMPUSTAT reported acquisition data, and our own analysis of M&A activity to 
perform robustness checks on our model estimates reported in Section 6 
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private!equity! and/or!venture!capital! funding.!Searches! included! the!historical!names!of!firms!listed! in! COMPUSTAT! to! capture! their! full! investment! history.! As! the! vast! majority!of! firms!receiving!investment!from!private!equity!funds!had!previously!received!venture!capital,!for!the!remainder!of!the!paper!we!refer!to!these!firms!as!venture!capital!backed.!
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%Figures!2!and!3!also!provide!an! important!context! for! the!study!showing! the!evolution!of!the!pattern!of!growth!over!time:!the!kernel!density!plot!of!the!evolution!of!logged!differenced!sales!growth!rates!over! time!(Figure!2a)!with!an!overall!probability!density!plot!of!sales!growth!for!the!period!1963Y2002!(Figure!2b)!and!the!changing!level!of!kurtosis!of!growth!rates!(Figure!3).!Taken! together,! these! figures!help!motivate!our!study!since! they!show!the! importance!of!not!assuming! a! normal! distribution.! Figure! 2a! shows! clearly! how! the! range! of! growth! rates!represents! increasing! variety! of! firm! performance! over! time.!We!notice! that! from!the!1980s!onwards! both! the! range! of! growth! rates! increases! dramatically,! and! the! density! of! the!distribution! close! to! the! mean! increases.!However,! the!probability!of! firms!attaining!extreme!high! (and! low)!growth,!as!measured!via! the!kurtosis!of!growth! (Figure!3)!also!increases!over!time.! Over! time! high! growth! event! observations! increase! in! size,!but!also!occur!with!greater!frequency,!such!that!the!distribution!of!growth!becomes!increasingly!characterized!as!fat!tailed.!!!Part!of! the!evolution!of!the!nature!of!high!growth!may!be!explained!by!the!presence!of!SME!in!our!data.!We!previously!noted! the! increasing!composition!of!SME!firms!in!our!data!over!time.!Investigating!the!growth!rates!of!HGF!in!our!data!show!SME!firms!achieving!growth!rates!above!either! the! 80%! or! 90%! quantile! were! approximately! 65%! and! 78%!of! firms,! respectively.!A!similar!pattern! is! found! for! the!worst!performing! firms,!where!80%!and!55%!of!observations!below!the!10%!and!20%!quantiles,! respectively,!are!also!due!to!SME!performance.!In!the!midYrange!quantiles!of!growth,!the!reverse!is!true;!where!at!least!69%!of!growth!observations!in!the!midYrange!quantiles!belong! to! large! firms.!Thus!extreme!performance!appears!to!have!a!strong!connection! to! SME! firms,! whereas! moderate! performance! is! more! likely! to! result! from! the!traditional! large! pharma.! But! what! is! happening! during! this! time! in! terms! of! the! underlying!patterns!of!individual!high!growth!firms?!!Next! in! Table! 1a! we! examine! a! list! of! fastest! annual! growth! observations! by! firm! (log!differenced!sales!growth),! including!details!of!firm!characteristics,!the!year!of!the!high!growth!event!and!market!share! for! that!year.!We! include!both!patenting!persistence!(those!firms!that!have! patented! 5! years! in! a! row)! and! whether! the! firm! had! venture! capital! backing! as!well.!Evaluating! the!names!of!companies!in!this!list!indicates!a!low!impact!group,!in!terms!of!market!
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share.!In!fact,!firms!with!high!growth!observations!are!also!likely!to!experience!low!growth!too!(as!indicated!by!firm!names!in!italics).!!!Table!1a:!Top!20!high!growth!firms!1951Y2007!(italics!indicate!firm!also!features!in!bottom!10%!growth!performance!list!in!at!least!one!year)!!Name! R&D!intensity*! VC#! Persistent!patenting#! Log!difference!growth! Sales!($m)+! Year! Public!age!(years)! Mkt!share!%!
NOVADEL!PHARMA!
INC! ! !56%! 1! 0! 5.43! 0.17! 2004! 7! 0.0001%!
EMISPHERE!
TECHNOLOGIES!INC!








40%! 0! 0! 4.30! 2.22! 2001! 7! 0.0015%!
MEDEVA!PLC! 157%! 0! 0! 4.18! 62.10! 1990! 2! 0.0826%!
QUIGLEY!CORP! 5%! 0! 1! 4.18! 32.59! 1997! 2! 0.0230%!
SPECTRUM!
PHARMACEUTICALS!
INC! 96%! 0! 0! 4.02! 0.92! 2002! 8! 0.0006%!
NATUREWELL!INC! 2%! 0! 0! 3.97! 0.45! 2002! 2! 0.0003%!
CARDIOME!PHARMA!
CORP!




67%! 1! 1! 3.84! 13.32! 1996! 5! 0.0091%!
DURECT!CORP! 72%! 1! 1! 3.57! 1.33! 2000! 3! 0.0009%!
ADOLOR!CORP! 26%! 1! 1! 3.41! 0.56! 2001! 8! 0.0004%!
MGI!PHARMA!INC! 15%! 1! 0! 3.41! 2.40! 1990! 12! 0.0032%!




7%! 0! 0! 3.36! 3.90! 1989! 4! 0.0055%!
NEXSTAR!PHARMACEUTICALS! 116%! 1! 1! 3.21! 23.93! 1994! 5! 0.0204%!
ABLE!
LABORATORIES!INC!
27%! 0! 0! 3.20! 6.51! 1997! 9! 0.0046%!
VEREX!
LABORATORIES!INC!
9%! 0! 0! 3.19! 0.28! 1988! 7! 0.0004%!
CORTEX!
PHARMACEUTICALS!
INC! 113%! 1! 0! 3.15! 1.37! 1999! 12! 0.0010%!
ANORMED!INC! 13%! 0! 1! 3.14! 3.76! 1998! 7! 0.0025%!*R&D!intensity!is!calculated!as!a!percentage! of!lagged! asset!value.!Excludes!firms!with!fewer! than! six!years!of!recorded! data.! #Measured! as!a!dummy!variable;! (e.g.!For!VC:!1!=!venture! capital!backed!0!=!no!venture! capital).!+Rebased! to!1982Y84!!!
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Table!1b:!Top!20!firms!(1951Y2007)!by!number!of!years!of!growth!in!the!90th!percentile!!Name! Mean!sales!($m)! Mean!R&D!intensity! VC#! Persistent!patenting#! Freq! %!time!above!90th!growth!percentile!
MDRNA!INC! 2.22! 53%! 0! 0! 8! 38%!
LESCARDEN!INC! 0.18! 36%! 0! 0! 6! 35%!
MACROCHEM!CORP/DE! 0.17! 32%! 0! 0! 6! 35%!
MGI!PHARMA!INC! 16.79! 28%! 1! 0! 6! 24%!CHANTAL!PHARMACEUTICAL!CORP! 1.71! 57%! 0! 0! 5! 38%!
COLUMBIA!
LABORATORIES!INC! 5.88! 45%! 1! 1! 5! 26%!
ARONEX!
PHARMACEUTICALS!INC! 1.29! 70%! 1! 1! 5! 56%!
CARACO!
PHARMACEUTICAL!LABS! 17.89! 42%! 0! 0! 5! 36%!
DEPOMED!INC! 2.87! 102%! 1! 1! 5! 45%!
IMMTECH!
PHARMACEUTICALS!INC! 1.22! 328%! 1! 0! 5! 50%!ALCIDE!CORP! 4.05! 17%! 1! 1! 4! 21%!CYPRESS!BIOSCIENCE!INC! 1.22! 45%! 1! 0! 4! 21%!
NOVA!
PHARMACEUTICAL!
CORP! 10.87! 30%! 1! 1! 4! 57%!
PHARMACEUTICAL!
FORMULATIONS! 19.46! 11%! 0! 0! 4! 18%!
VEREX!LABORATORIES!
INC! 0.24! 41%! 0! 0! 4! 31%!
EMISPHERE!
TECHNOLOGIES!INC! 1.58! 45%! 0! 1! 4! 21%!
REPROS!THERAPEUTICS!
INC! 1.61! 47%! 1! 0! 4! 36%!
IMPAX!LABORATORIES!
INC! 6.71! 28%! 1! 0! 4! 67%!
MELDEX!GROUP!PLC! 4.51! 3%! 0! 0! 4! 57%!
ANGIOTECH!
PHARMACEUTICALS! 38.14! 14%! 0! 1! 4! 44%!*R&D!intensity!is!calculated!as!a!percentage! of!lagged! asset!value.!Excludes!firms!with!fewer! than! six!years!of!recorded! data.! #Measured! as!a!dummy!variable;! (e.g.!For!VC:!1!=!venture! capital!backed!0!=!no!venture! capital).!!Table!1a!suggests!considerable!variation!within! the!high!growth!category,!indicating!potential!difficulties!in!trying!to!target!highYgrowth!firms!without!an!understanding!of!the!characteristics!which!may!drive!their!growth.!Our!measures!of!firm!characteristics!in!Table!1a!show!firms!with!a!wide!range!of!R&D! intensities;! firms!with!and!without!venture!capital!investment;!as!well!as!persistent! and! nonYpersistent! patenting! firms.! In! addition! other! characteristics,! such! as! size!(sales)! or! years! on! the! stock! market! (proxy! for! age)! also! show! variation.! Even! those! firms!repeatedly! achieving! growth! performance! above! the! 90th! percentile,! as! shown! in! Table! 1b,!highlight! variability! in! firm! R&D,! VC,! and! patenting! persistence!characteristics.!Although,! the!
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names!of!the!largest!pharmaceutical!firms!are!notably!absent!from!Table!1a!and!1b,!the!full!list!of!firms!achieving!growth!above!the!90th!percentile!includes!firms!with!annual!sales!in!excess!of!$1billion.!Frequently! it! is!expected! that!high!growth! is!directly! linked!with! innovative,!young!SME! firms;!our!descriptive!analysis!presents!a!far!more!complex!picture.!Next,!we!examine!the!pattern!of!competition!and!innovation!in!pharma.!!
4.%Dynamics%and%the%competitive%environment%%!Because!in!Section!5!we!will!look!at!the!different!behavior!of!high!growth!and!low!growth!firms!
$+' #*()'.5( !Ycycle,! it! is! important! to!get!a! sense!of!how!the! industry! has!changed!over!time.! Gambardella! (1995)! argues! that! before! 1980! the! 4search! regime5! in! pharma! was!characterized!.4'#$"('5%'$((#,!'&*#))($"$!*!(#)$screened.!This!phase!did!not! favor! large! firms!as!much!as!the!following!period,!which!he!calls!
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!!First!we!look!at!the!degree!of!competition!in!pharma,!looking!at!the!overall!concentration!of!the!industry4.! As! discussed! above,! different! studies! have! found! that!competitive!pressures!affect!how!much!money! is! spent!on!R&D:! too!much!competition! threatens! appropriation;! too!much!concentration!reduces!innovation!incentives!and!capabilities!(Scherer!1967;!Aghion!et!al.!2005).!We! look!at!both! traditional! indices!of! competition! (concentration)!and!more!dynamic!indices!
))+#*(.)$("%(/# )"%$')#$4*'#5)$'(3!!As! regards!concentration,!our!data!show! from!1950!to!2007!an!industry!structure!formed!of!a!consistent! core! of! large! firms,!as!evidenced!by! the!CR20!(Figure!6).! In! fact!over! the! full!data!period,!only!43!different!firms!feature!in!the!CR20,!of!which!28!appear!for!more!than!10!years.!However,! despite! a! general! persistence! of! concentration! in! market! shares! within! the! top!20!firms,! the! concentration! ratios! and! particularly! the! two! concentration! indices! Herfindahl! 8!Hirschman! (HHI)! and! HallYTidemann! (HTI)5! (Figure! 7)! reflect! a! trend! of! declining! market!concentration! until! the! 1980s.! Declining! concentration! occurred! as! the! number! of! entrants!rapidly! increased,!whilst!exits! remained! low.! In! the!post!1980!period!concentration!remained!low,!whilst!entry!and!exit!were!high.!!Next!we!consider!the!intensity!of!competition!in!terms!of!instability,!churn!and!turbulence,!the!
4"' ) (' #()!). #-51 I! is! used! to! capture! the! intensity! of! interYfirm! competition,!regardless! of! the! degree! of! concentration! (Hymer! and! Pashigian! 1962).! It! measures! the!summation!of! the!absolute!change! in!market!shares! in!each!year.!Hymer!and!Pashigian!argued!that!this!was!a!superior!measure!of!competition!because!it!could!be!very!high!even!in!industries!with!few!firms.!And!conversely,!if!it!was!low!in!industries!with!many!firms,!this!was!a!sign!that!
                                                 
4 Note here market is defined as the total annual sales of COMPUSTAT firms . 
5 The Hall-Tideman Index (Hall and Tideman 1967), an alternative to the Herfindahl-Hirshman index (HHI) 
(HHI is calculated as a sum of the squares of market share for each Pharma firm), includes information on the 
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those! firms! were! not! feeling! the! pressure! to! differentiate! from! competitors! (seeking! higher!market!share).!!!








%'$5(!postY1980!with!increasingly!higher!peaks!of!instability.!Instability!index!values!peak!at!0.21!and!0.19! in! the!postY1980!period,! compared! to!peak! index!values!of!0.13!and!0.11!in!the!preY1980!period.!Whilst!the!preY1980!period!reflected!instability!as!a!result!of!changing!market!share!among!a!relatively!stable!and!small!group!of!firms,!post!1980!the!increasing!entry!and!exit!contributed! to!greater! changes! in!market!shares!of! individual! firms.!Mazzucato!(2002)!argues!that! the! instability! index! is!particularly!useful! for!capturing!periods!of!creative!destruction.!In!many! industries! the! instability! index! is!highest!precisely!when! innovation! is! the!most! radical,!not!necessarily!the!period!in!which!there!is!just!high!entry!(Mazzucato!2002).!!Examining! the! relative! level! of! instability,! concentration,! entry! and! exit! can! be! used! to!summarize!the!evolution!of!the!competitive!environment!broadly!into!two!periods,!pre!and!post!1980,! as! shown! in! Table! 26.! During! the! first! period! relatively! few! new! firms! entered! the!pharmaceutical! industry!and!still! fewer!gained!significant!market!share!upon!entry.!Post!1980,!
                                                 
6 Here we are not arguing that there should be a specific date or breakpoint in the competitive regime, but that 
the pre/post 1980 distinction is a useful method to group the data to capture differences in the competitive 
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5(Gambardella! 1995),! taking! advantage! of! changes! in! the! continued! development! of! new!research! tools! (Orsenigo! et! al.! 2001),! whilst,! simultaneously,! the! introduction! of! BayhYDole!
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competitive! environment;! competition! occurred! within! a! concentrated! firm! group! at! a! time!when! industry!revenue!was!rising,!whilst!R&D!intensity!was!relatively!stable.!In!the!post!1980!period! competition! was! fierce,! reflected! by! rising! instability! of! market! shares! (a! proxy! for!strong! competition)! increasing!variety! in!growth!performance,!and!changes! in! the!underlying!technology!together!with!a!sharp!rise!in!R&D!spending.! !!We!use!these!two!periods!to!investigate!how!the!competitive!environment!in!pharma!influences!the! relationship! between! firm! characteristics! and! growth,! paying! special! attention! to! the!innovation!growth!relationship.!We!describe!our!method!of!analysis!in!Section!5.!!!
5.%HIGH%GROWTH%FIRMS:%A%QUANTILE%REGRESSION%APPROACH%Quantile!regression!methods!allow!us!to!look!at!high!growth!firms!more!systematically.!We!test!for! the! relationship! between!R&D/innovation!and!growth,! conditional!on!growth,! controlling!for!other! firm!characteristics,! looking! for!differences! in!these!relationships!pre!and!post!1980.!Previous! studies! of! the! R&D! growth! relationship! have! used! quantile! regression,! but! our!approach! is! to!use!penalized! fixed!effect!quantile! regression,!which! is!able! to! take!account!of!both! the!heterogeneity!of!growth!rates! in!pharma!(as!shown!in!Figure!2)!as!well!as!to!control!for!firm!specific!fixed!effects.!!!
5.1.%Quantile%regression%approach%Analysis! of! logged! difference! sales! growth! data! in! Figures! 2! and! 3! suggest! a! fatYtailed!distribution! which!prevents!using!Gaussian!assumptions! (see!Bottazzi!and!Secchi!2006! for!an!extended! discussion).! In! such! cases! it! is! appropriate! to!use! quantile! regression! techniques! to!produce!estimates! robust! to!outliers! in! the!dependent!variable!(Koenker!and!Bassett!1978).!In!quantile! regression,! observations! of! extreme! growth! (either! positive! or! negative)! are! not!disregarded!as!outliers!and!can!be!used!to!estimate!the!influence!of!firm!characteristics!on!sales!growth! at! different! quantiles! of! the! conditional! distribution! in! order! to! understand! the!determinants!of!growth!for!top!performers.!!!We! estimate! the! coefficients! of! each! independent! variable! (i.e.! the! partial! derivative! of! the!conditional!quantile!of!growth! ( K!with!respect!to!a!particular!independent!variable)!at!10%,!25%,! 50%,! 75%,! 80%,! 90%! quantiles! using! Koenker! (2004)! penalized! fixed! effect! quantile!regression! to!control!for!unobserved!firm!fixed!effects,!applying!bootstrapped!standard!errors7.!!For!comparison!we!also!report!regression!results!for!OLS!and!least!squares!(within)!fixed!effect!estimators! with! robust! errors! using! HuberYWhite! sandwich!estimators.!We!do!not! report! the!standard! Koenker! and! Basset! (1978)! quantile! regression! results! as! they! yield! very! similar!results!to!those!reported!for!the!penalized!fixed!quantile!estimates.!!
5.2%Variables%!Our!dependent!variable! is!growth,!measured!as!an!annual!growth!rate!using!the!sales!revenue!of!firms,!taking!logged!differences!of!annual!sales!observations.!As!previously!described,!we!find!that! high! growth! is! a! short! term! feature! of! firms! and! we!measure! annual! growth! rates! to!account! for! the!changing!dynamics!of!growth!over!time.!As!some!pharma!firms,!particularly!in!the!post!1980!period!enter!COMPUSTAT!for!relatively!short!periods,!using!annual!growth!rates!
                                                 
7 See supplementary online material for details. 
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provides! a! series! of! observations! to! evaluate!changes! in!performance8.!Although!a!variety!of!different!growth!measures!are!proposed! in! the! literature,!we!use!sales!growth!because! this! is!the!most!commonly!used!measure!of!growth!in!the!literature,!thus!permitting!a!comparison!of!our!work,!and!also!represents!a!key!performance!metric!upon!which!firms!are!judged!(Delmar!et!al.!2003).!!!Independent! variables! calculated! from! our! data! sample! include,! size,! R&D! intensity,! venture!capital! (VC),! innovation!persistence! (persist),!age,!R&D!scale,!and!a!set!of!variables!related!to!M&A.!!To!measure! firm!size!we!use!sales!data!recorded!by!COMPUSTAT,!in!agreement!with!previous!studies,! such! as! Coad! and! Rao! (2008).! We! also! investigate! using! employment! data! as! an!alternative!measure!of!size,!and!find!very!similar!results,!and!a!strong!correlation!between!sales!and!employment.!However,!as!employment!has!missing!observations!we!prefer!to!use!sales!as!our!main!measure!of!size.!Given!our!data!includes!both!large!and!small!surviving!firms,!based!on!previous! literature! we! expect! size! to! have! a! negative! relationship! with! growth! (Audretsch!1995).!!To! measure!R&D! intensity!we!combine!six!different!R&D!measures! into!one!single!composite!R& #)#(). 4#-5 +'! + ) *( $ %'#%! $"%$##) #!.((3  $ )$combine!different!R&D!measures!helps! to!avoid!potential!bias!from!focusing!on!any!individual!R&D!measures.! Our! R&D! variable! is! calculated! from! R&D! intensity! and! R&D! stock! intensity!measures.! R&D! intensity! in! a! period! is!given!by! the!annual!R&D!expenditure!scaled!by!a!one!period!lagged!measure!of!firm!size.!R&D!stock!intensity!is!obtained!by!first!calculating!an!annual!measure! of! R&D! stock,! using! the! perpetual! inventory! method! outlined! by! Hall!and!Mairesse!(1995).!R&D!stock!is!then!depreciated!using!an!annual!discount!rate!and!scaled!by!a!one!period!lagged!measure!of! firm!size! to!give!R&D!stock! intensity.!Although!sales!is!frequently!used!as!a!choice!of! scaling! factor! in! the! literature,!Brown!et!al.! (2009)!suggest!asset!value!to!be!a!more!stable!scaling!factor!than!revenue.!We!use!both!sales!and!revenue!as!a!size!scaling!factor!to!give!two!sets!of!R&D!intensity!measures,!one!set!scaled!by!lagged!sales,!the!other!scaled!by!assets.!In!each! set! we! include! a! simple! measure! of! R&D! intensity,! and! two! measures! of! R&D! stock!intensity;! using! a! depreciation! discount! of! 15%! and! then! 30%! (Hall! and!Oriani!2006).).!The!result! is! that!using! three!different!calculations,!with!two!different!scaling!factors,!we!produces!six!measures!of!R&D!intensity!as!inputs!into!the!principle!component!analysis.!!A!principle!component!analysis!was!applied!to!the!six!different!measures!to!capture!as!much!as!possible! of! the! original! variance! in! the! different! R&D! indicators.! The! first! component! was!retained!explaining!52%!of!the!total!variance!analyzed.!We!use!the!first!principle!component!as!a!composite!index!m(*'$4R&D!intensity5#$*'#!.((9.!However!we!stress!that!the!broad!pattern! of! results! described! in! Section! 6! are! similar! if! we! use! individual! measures! of! R&D!intensity!discussed.!!
                                                 
8 We check our model (reported in Section 6) using 3 year logged differenced growth rates and find similar 
results compared to using the one period measure, however because of the lag structure of model used in our 
estimations it does significantly reduce the sample size, excluding firms with less than eight years of data. If our 
analysis is to help reveal the characteristics of all high growth firms and inform policy, it is important to avoid 
excluding firms, as policy makers cannot know ex-ante which firms will fail.  




Our! R&D! intensity! measure! is! used! to! determine! whether! innovation/R&D! activity! has! any!influence! on! growth! experienced! by! firms.! Recent! quantile! based! results! indicate! we!should!expect! the!impact!of!R&D!activity!tends!to!increase!as!we!move!up!the!conditional!distribution!of!sales!growth!(Coad!and!Rao!2008).!!!To!control!for!the!growth!effect!of!firms!receiving!venture!capital,!we!construct!a!time!varying!dummy!variable!equal! to!one! for!any! firm!after! receiving!venture!capital! (zero! for!those!that!have!never!received!VC).!Once!a! firm!has!received!VC,! this!reflects!a!permanent!change!in!the!dummy!variable.!One!potential!concern!would!be!that!VC!is!responsive!to!the!signaling!effect!of!high!growth!potential!firms.!In!the!signaling!role!VC!firms!are!only!responsive!to!selecting!firms!
,)()'$#%$)#)!1*)#$)#(('!.)#( 4$5 )$'+'$,) # ) '"3 !However! it! is! important! to!note! that! in! this!application! the!majority!of! firms!receive!VC!at!an!early!stage!of!development,!well!in!advance!of!the!time!period!covered!by!this!dataset!and!this!reduces!the!possibility!of!bias!in!our!results!from!endogeneity!of!the!VC!measure.!In!many!cases!the! direct! influence! of! VC! diminishes! post! IPO,! as! investors! sell! their! shareholding! to!obtain!return,! so! the! measure! is! used! to! assess! whether! in! general! receiving! VC! influences! growth!performance.!!Our! measure! of!VC! tests! the! lasting! impact!of!VC! involvement!on! the!growth!performance!of!firms.!It!cannot!distinguish!between!the!coaching!and!selection!performance!of!VCs!as!described!by!Baum!and!Silverman!(2004),!but!does!act!as!a!control!for!the!effects!of!VC.!We!would!expect!given! the!selection!effect!and! the!contribution!of! resources!and!coaching,! should!both!have!a!positive! influence!on!growth,!so!we!expect!to!find!a!%$()+#!()#4"%'#)5$)+).on!performance.!!!To! control! for! the! relationship! between! innovative! output! and! performance! we! calculate! a!measure! of! innovative! output! persistence! using! the! method! proposed! by! Demirel! and!Mazzucato! (2012).! In!pharma!an!output!would!be!considered!a!pharmaceutical!product.!In!the!absence! of! detailed! historical! data! on! pharma! outputs,! patents! can! be! used! as! a! proxy! for!innovative! outputs.! However,! as! a! pharmaceutical! innovation! usually! requires! more! than! a!single! patent,! successful! pharma! are! expected! to! be! persistent! innovators,! able! to!produce!a!series!of!patents.!Thus!we!use! the!NBER!patent!database! to!generate!a!measure!of!innovation!persistence,! persist,! measured! using! a! dummy! variable! equal! to! one! for! any! firm! that! has!patented!consecutively! in! the!previous! four!years.!We!note! that!we!already!use!a!measure!of!R&D!intensity!which!includes!components!related!to!R&D!stock,!and!so!may!reflect!R&D!4#%*)5persistence.! We! therefore! use! patenting! persistence! as! a! measure! of! innovation! 4$*)%*)5persistence.! We! would! expect! innovation!persistence! to!have!a!positive! influence!on!growth,!particularly!for!HGF.!!To!control!for!the!effects!of!age!on!growth,!we!determine!the!public!age!of!firms!in!the!dataset.!Following!Brown!et!al.!(2009)!we!include!the!log!of!firm!age!to!control!for!the!lifeYcycle!of!each!firm!using!the!number!of!years!in!the!COMPUSTAT!dataset!as!a!proxy!for!age10.!Davidsson!et!al.,!(2002)! find! a! negative!relationship!between!age!and!growth;! likewise!our!expectation! is! that!younger!firms!will!grow!faster.!!
                                                 




In! addition! to! our! R&D! intensity! composite! measure,! we! also! measure! the! scale! of! R&D!operations! using! total! R&D!expenditure!of!each! firm.!However,! rather! than!measure!absolute!R&D! spending,! we! express! R&D! scale!as!a! relative!measure! to!capture! the!effect!of! investing!greater!amounts!of!R&D!than!competitors.!This!reflects!the!expectation!that!pharma!gains!from!
4$#$"($(!#-%'"#))$#5:)#!@>>>;1(*))+#(##)0scale,! allows! firms! to! gain! greater! experimental! throughput,! and! so! a! greater! likelihood! of!innovative! success! and! ultimately! revenue! growth.! We! calculate! a! variable,! R&D! scale! to!measure! above! average! annual! R&D! expenditure! relative! to! all! the! firms! in! the!dataset!each!year.! This! is! expressed!as!a!dummy!variable,!equal! to!zero!w# '"5(0-%#)*' (either!below!or!equal! to! the!annual!average,!otherwise!it!is!set!to!one.!As!we!already!include!a!measure!of!firm!size!based!on!sales!revenue,!our!R&D!scale!variable!is!constructed!to!control!for!the!effects!of!being!above!average! in! the!amount!of!R&D!investment!after!controlling!for!R&D!intensity,! and! provides! a! different! perspective! on! the!R&D!growth!relationship11.!We!expect,!after! controlling! for! other! characteristics,! those! firms! that! increase! R&D! scale! above! the!industry!mean!will!gain!growth!advantage.!!To! control! for! the! effect! of!acquisitions!on!growth!we! investigate! two!different!measures!of!acquisition!activity.!First!we!use!the!COMPUSTAT!recorded!annual!acquisition!expense!variable!
(Acq!value)! as!a!general!measure! to! record! the!amount! invested! in!all!acquisition!activity!in!a!given! firmYyear.! However,! as! firms! may! undertake! acquisitions! for! a! variety! of! longYterm!strategic! reasons,! not! simply! to! acquire! a! short! term! increase! of! sales,!we!also!use!our!own!collected! data! on! M&A! to! calculate! a! second!measure! using! a! dummy! variable! (Acq! DV)! to!capture!acquisitions!of!other!significant!pharma!which!are!expected!to!directly!influence!shortYterm!sales!growth.! If! a! firm!makes!an!acquisition!of!a!COMPUSTAT!list!pharma!in!a!particular!fiscal! year,! then! we! set! the! dummy! variable,! Acq! DV,! for! that! firmYyear! equal! to! one.! The!acquisition!of!another!pharma! firm!can!be!expected! to!dramatically! increase! the!sales!growth!rate!of! the!parent!pharma.!Neither!variable!accounts!for!changes!in!the!long!term!performance!of!a!firm!as!a!result!of!acquisition!activity.!!
5.2.%Modeling%the%R&D]growth%relationship!Our!methodology!follows!a!trajectory!established!by!studies!(Gibrat!1931;!Mansfield!1962;!Hall!1987;!Hart!and!Oulton!1996)!that!seek!to!determine!the!existence!of!regularities!of!firm!growth!in!industrial!dynamics.!!!In! this! section!we!outline! the!model!used! to!evaluate!how!sales!growth!( K!is!related!to!R&D!and! innovation.! Our! core! contribution! is! to! firstly! understand! how! changing! industry! level!dynamics!influence!the!R&DYgrowth!relationship!and!secondly!investigate!additional!innovation!variables! that!help!explain!growth!performance.!Our!selected!model!extends! the!conventional!Gibrat! type!sales!growth!equation!where! firm!growth!rates!are!usually!regressed!on!size,!here!measured!as!log!of!sales!and!one!period!lag!of!growth!( 4
92+)!to!control!for!autocorrelation!of!growth! (Evans!1987).!Our!model! includes!a! composite! index!measure!of!R&D! intensity! (R&D!
intensity)! to! test! for! the!relationship!between!R&D!and!growth,!a!dummy!variable!for!venture!capital!(VC),!patent!persistence!(persist),!and!R&D!scale!(R&Dscale),!all!of!which!enter!with!one!
                                                 
11 R&D scale is strongly correlated with annual R&D expenditure (corr = 0.78), however rather than investigate 
the effect of small changes in R&D expenditure on growth, we investigate the extent to which above average 
annual R&D expenditure has on growth  therefore giving a relative R&D performance measure. R&D scale 
also has a weak, but negative correlation with R&D intensity. 
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period! lags.! We! also! include! the! log! of! public! age! (age),! and! to! control! for! common!
"'$$#$"#!*#(,!($#!*)"*""($'.':GjK.!!To!account!for!the!possibility!of!patenting!activity!being!correlated!with!the!errors!in!the!model,!potentially! as! a! result! of! growth! and! patenting! being! stimulated! by! an! unobserved! variable,!endogeneity! tests!were!run!using!instrumental!variables!for!patenting!activity!including!lagged!measures! of! patenting! persistence! and! also! a! patenting! dummy! variable! recording! years! in!firms! successfully! applied! for!a!patent.!The!null!hypothesis!of!exogeneity! in!Durbin!and!Wu8Hausman!tests!were!not!rejected.!!!The!basic!model!is!defined!as:!
 49 A % ? &+J!4
92+K ? &, 4
92+ ? &-	!4
92+ ? &.4
92+ ? &/ !!"4
92+
? &0J49K ? &1	!4
92+ ? '9 ? #49!!and!
 49 A J!49K@ J!4
92+K!!As!a!robustness!test!we!extend!the!model!to!test!for!the!effects!of!M&A!and!growth!persistence!and!report!results!for!the!90%!growth!quantile12.!To!control!for!acquisitions!we!include!the!log!of!acquisition!value!(Acq!value)!to!capture!the!current!effect!on!growth,!with!a!one!(Acq!value1)!and!two!(Acq!value2)!period!lag!to!try!and!capture!any!effect!of!acquisition!on!future!growth13.!We! repeat! and! reYestimate! the! model! including! our! alternative! dummy! variable! measure! of!acquisition! activity! (Acq! DV,! Acq! DV1,! Acq! DV2),! using! the! same! lag! structure.! Finally,! via!stepwise!regressions!we!report!the!effects!of!additional!two,!and!three!period!growth!lags14.!!!Although!the!construction!of!the!basic!regression!requires!a!minimum!of!3!consecutive!years!of!observations!for!each!firm,!because!as!a!robustness!check!we!test!for!two!additional!lags!in!the!model,! we! use! a! consistent! data! set! which!excludes! firms!with!greater! than! five!consecutive!years!of!history15.!The!sample! is! restricted! to!1963Y2002!because!of!the!unreliability!of!patent!data!in!the!1950Y1962!and!2003Y2007!periods,!as!noted!in!Section!3.116.!!In!Table!3!we!report! summary!annual! statistics! for!our!data!sample!data!which!only!includes!firms!with!greater!than!5!years!of!data!history.!In!Table!4!we!report!the!correlation!coefficient!for!the!sample.!Next!we!discuss!the!estimates!of!the!model.!! !
                                                 
12 Results for all quantiles were inspected, and are available. However, as our main interest is HGF, and the 
main results are robust to including M&A activity, we have only reported the results for the top performing 
firms. 
13 Similar to Danzon et al. (2007) we look for the effect of M&A on subsequent firm performance, as well as in 
the acquisition year. 
14 Note, lags of R&D intensity, R&D scale, Sales, VC, and Persist were tested, but were either highly collinear 
or statistically insignificant and could be dropped without implication to the results reported. 
15 In fact adjusting this restriction to allow for firms with between a minimum of three (without additional lags 
in the model) and ten years of history yields very similar estimation results to those reported in Section 6 for 
R&D intensity and VC.  
16 Regressions run on the 1951-2007 period without patenting persistence give a similar pattern of results for the 

























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6.%Quantile%regression%results%In! Tables! 5,! 6! and! 7! we! present! the! results! for! the!estimates!of! the!coefficients!of! the!basic!regression!model!described! in! Section!5.!We!briefly!discuss!the!results!for!the!estimates!of!the!full! data!period! (1963Y2002)! in!Table!5.!The!results! in!Table!6!and!7!provide!our!main! focus!showing!how!the!coefficient!of!R&D! intensity!changes!between! the! two! time!periods.!Table!6!shows! the! results! for! the! period! 1963Y1980,! Table! 7! shows! the! results! for! the!period!1981Y2002.!In!each!table!we!report!the!estimates!of!model!coefficients!for!the!pooled!OLS,!fixed!effect!estimator! as! well! as! the! penalized! fixed! effect! (FE)! quantile! regression.! The! results! of! the!robustness! tests! for! the!90%!quantile,!including!measures!of!acquisition!and!additional!growth!lags,!are!reported!in!Tables!8!and!9.!!!The!quantile!regression!results!in!Table!5!for!the!full!period!sample!(1963Y2002)!using!the!basic!model!presented!in!Section!5.2!are!broadly!in!agreement!with!previous!studies.!Our!measure!of!firm! size,! sales,! is! negative! for! high! growth! firms,! indicating! that! smaller! firms! grow! faster.!Lagged!growth!also!has!a!negative!influence!on!firm!growth!performance!in!the!90%!quantile!of!growth,!indicating!an!absence!of!high!growth!persistence.! !!Our!main!measure!of! interest,!R&D! intensity! is!positive!and!statistically!significant!at!the!50%!quantile! and! above.! For! firms! in! low! growth! quantiles,! increasing! R&D! intensity! has! no!statistically!significant!effect,!investing!in!R&D!would!only!seem!a!good!strategy!for!high!growth!firms.! In!agreement!with!previous!studies!(e.g.!Coad!and!Rao,!2008)!the!importance!of!R&D!on!growth,! rises!over!performance!quantiles.!In!fact!the!size!of!the!coefficient!of!R&D!intensity!at!the! 90%! quantile! is! close! to! three! times! greater! than! at! the! median! level.! Interestingly,! the!benchmark! of! pooled! OLS!and!FE!panel! regression!results! show!a! statistically! significant!and!positive!influence!of!R&D!on!growth,!reporting!coefficients!similar!in!strength!to!those!reported!at! the!50%!quantile,!but! severely!underestimate! the!strength!of! this! relationship!at!the!higher!growth!quantiles.!!!!In! agreement!with!our!approach! to!understanding! the!characteristics!of! firms,!Table!5!shows!our!measure!of!VC! is! found! to!only! influence! the!growth!performance!at!the!higher!quantiles.!For!instance!at!the!90%!conditional!quantile,!holding!all!other!independent!variables!constant,!a!firm! that!has! received!VC!experiences!an! increase! in! the!growth!measure!of! 0.16.!Considering!the!log!difference!growth!rate!of!the!sample!at!the!90%!quantile!is!0.63,!the!coefficient!of!VC!at!90%! conditional! quantile! represents! a! significant! additional! growth! advantage! for! those! VC!backed!firms.!Notably!the!pooled!OLS!regression!does!not!show!any!influence!of!VC!on!growth,!corresponding!with!our!observation! that! the!VC!8! growth!relationship! is!only!present!at!high!growth!quantiles.!!!Our! measure! of! innovation,! Persist! is! not! found! to! be! statistically! significant! at! any! growth!quantile! (or! in! the! sub! period! analysis! presented! in! Table! 6! and! 7).! This! result! may! not! be!surprising! as! many! persistent! patenting! firms! are! large,! and! so! the! influence! of! patenting!persistence!may!be!controlled! for!by!a!combination!of!R&D!scale,!as!well!as!VC!which!targets!smaller! firms! with! a! history! of! patenting17.! Also,! by! construction,! a! measure! of! patenting!persistence! may! not! show!considerable!variation!over! time!8!being!a! firm!strategy!which!by!definition!can!only!be!achieved!with!significant!and!prolonged!investment,!so!may!be!part!of!the!
                                                 




estimated!fixed!effect.!In!quantile!regression!models!without!fixed!effects,!patenting!persistence!is! found! to! have! a! statistically! significant! and! positive! influence! on! growth! at! high! growth!quantiles.!!We!note! that!age! is!not!found!to!be!a!statistically!significant!predictor!of!growth.!We!note!that!age! is! strongly! and! positively!correlated!with!size! (sales),!patenting!persistence! (persist)!and!R&D!scale;!it!is!likely!that!some!of!the!effects!of!age!reported!in!previous!studies!are!controlled!for!by!additional!factors!included!in!our!model.!!Finally! we! note! that! including! R&D! scale! has!a!variable!effect!on!growth,! conditional!on! the!growth! quantile.! High! growth! firms! gain! additional! benefit! from! increasing! their! R&D!investment! above! industry! average,! even! after! controlling! for! R&D! intensity.! In!contrast! for!those! firms! in! lower!growth!quantiles,! the!reverse! is! true,! investing! in!R&D!to!achieve!above!average! R&D! expenditure! reduces! their! growth!performance.!This! supports!our!position! that!high!growth!is!not!an!exclusive!characteristic!of!small!firms.!!Whilst!the!results!in!Table!5!capture!the!effects!of!variables!in!our!model!on!growth!over!the!full!period,!our!main!interest!is!to!evaluate!the!impact!of!the!changing!competitive!environment!on!the! R&DYgrowth! relationship.! Figure! 10! shows! how!the!coefficient!of!R&D! intensity!changes!over! time,! using! the! same! model! reported! in! Table! 5,! however! applying! a! rolling! quantile!regression!over!9!year!periods18.! It!shows!that!for!HGFs!the!coefficient!of!R&D!intensity!at!the!90%!is!always!positive!post!1980,!but!for!significant!parts!of!the!preY1980!period!the!coefficient!of!R&D! intensity! is!negative.!The!reverse! is! true! for!the!poorest!performing!firms!in!each!nine!year!window,! that!appear! to!gain! from! increases! to!R&D! intensity! in!the!preY1980!period,!but!lose! from! increasing!R&D! intensity! in! the!post!1980!period.!In!order!to!further!investigate!the!influence!of! the!competitive!environment!on! the!R&DYgrowth!relationship!we!reYestimate!our!model!results!for!two!periods!1962Y1980!and!1981Y2002.!!
% %
                                                 
18 Here we use quantile regression, but without fixed effect as the rolling regression is produced using only a 9 





!!Table!6!shows!estimates!of!our!model!for!the!first!sub!period!1962Y1980.!We!note!that!firm!size,!innovation!persistence,!and!age!are!similar! to! those!reported!in!Table!5.!We!also!note!that!this!more! stable! competitive! environment,! as! might! be! expected,! is! broadly! characterized! with!positive! growth! persistence,! with! previous! growth! a! significant! and! positive! predictor! of!growth.!VC!remains!a!significant!predictor!of!growth,!but!for!growth!in!the!90%!quantile!only.!!Our! main! variable! of! interest! is! coefficient!of!R&D! intensity!and!R&D!scale.!R&D! intensity! is!statistically!significant!at!the!80%!and!90%!quantiles,!but!has!a!negative!influence!on!growth!for!the!fastest!growing!firms.!In!fact!we!only!find!evidence!of!a!positive!influence!of!R&D!intensity!on!growth!at! the!20%!growth!quantile.!At!remaining!quantiles!we!find!no!influence!of!R&D!on!growth.!In!contrast!the!influence!of!R&D!scale,!although!positive,!is!only!statistically!significant!for!top!growth!performers.!In!this!pre!1980!period!increasing!R&D!intensity!appears!to!act!as!a!drag! for! the! fastest! performers! and! irrelevant! to! the!growth!performance!of! the!majority!of!firms,!but!achieving!above!average!R&D!scale!counts!for!HGFs.!!Table! 7! shows! the! results! of! the! model! estimated! for! the! period! 1981Y2002.! The! post!1980!period! indicates! similar!outcomes!to!results!reported!for!the!full!period!(Table!5).!In!this!more!turbulent! period,! small! firms! appear! to!grow! faster,!as! shown!by! the!coefficient!of! sales,!but!there! is! an! absence! of! growth! persistence! 8! with! past! growth! inversely! related! to! current!growth!at! the!90%!quantile.!The!results! for! this!more!competitive!period,! show!that!only!the!fastest!growing!firms!benefit!from!R&D,!whether!from!increases!to!R&D!intensity,!or!achieving!R&D!scale.!As!before!VC!remains!important!for!the!fastest!performing!firms!having!an!influence!of!similar!strength!to!that!reported!in!Table!5.!!!






































































































































































































































































































































































































































































































































































































































































































































































In!each! table,! the! first! column!shows! the!results!without! including!R&D!scale! in!the!model,!in!case! including! this!variable!changes! the!estimate!of!R&D! intensity.!The!second!column!shows!the! effect! of! including! the! dummy! control! variables! for! acquisition! (Acq! DV);! this! measure!applies! to! the! post! Y1980! period! only19.! The! third!and! fourth!column!shows! the! influence!of!controlling! for!additional!growth!lags.!Finally,!the!fifth!column!repeats!the!acquisition!analysis,!this! time! using! the! logs! of! acquisition! value! (Acq! value)! reported! in! COMPUSTAT! for! both!periods,!instead!of!the!acquisition!dummy!variable!(Acq!DV).!!!We! note! that! our! results! for!R&D! intensity!and!R&D!scale! reported! for! the!post!1980!period!(Table!9)!are!robust!to!including!additional!control!variables!and!consistent!with!those!reported!in!Table!7.!!We!note!that!including!additional!lags!of!growth!appears!to!control!for!the!effects!of!VC!on!growth!which!may!be!a!result!of!VC!targeting!individual!firms!with!an!outstanding!history!of!growth.!!However,! in! the! preY1980! period! when! we!add!a! third! lagged!growth!variable,! the!results! in!Table! 8! show! that! R&D! intensity! and! R&D! scale! become! insignificant! and! the! size! of! the!coefficients! reduce!dramatically.! !The!effects!of!including!additional!lags!lend!further!evidence!to! confirm! that! preY1980! growth! is!more!predictable!and,!at!best,!unrelated! to! investment! in!R&D.! ! However,! although! postY1980!growth! is!generally!more!erratic!and! less!persistent,! top!performing! firms!can!gain!advantage! from! investing! to!increase!R&D!intensity!or!by!achieving!significant!R&D!scale.!!
7.%Discussion%and%conclusion%%
%The! results!provide! insights!on! )' )$, 4'$,)5 is!a!meaningful! category! in!innovation! policy.!We! find! that! it! is!a!very! transient!process!of!particular! firms950%!of! the!time! lasting! for!2!years!or! less,! and! that! it! is!not!homogeneous,!but! instead! includes!different!types!of! firms,!both!small!and! large,!and!with!both!high!and!low!R&D!intensities.!We!find!that!fast!growing! firms!gain! increased!performance! from! investing!more! intensely! in!R&D,!but!can!also! gain! additional! growth! from! achieving! a! scale! of! R&D! expenditure! above! the! industry!average.!In!combination!these!firm!characteristics!offer!an!important!insight!into!the!drivers!of!high!growth,!and!of!outlier!behavior.!The!growth!advantage!pharma!firms!gain!from!investing!in!R&D! is! specific! to! the! type!of!R&D! investment! (achieving!higher!intensity!vs.!achieving!above!average!scale)!and!also!determined!by!the!competitive!environment!facing!the!firm.!!!Unlike!other!studies,!we!control!for!the!competitive!environment!and!find!that!it!matters.! !Differences! in! the! relationship! between! R&D! and! growth! (between! quantiles)! matters! only!when!proxies!for!the!competitive!environment!are!controlled!for.!High!growth!firms!that!focus!on! increasing!R&D! intensity! fail!to!realize!any!growth!advantage!when!the!competition!regime!is! relatively! weak! (high! concentration,! market! share! stability! and! relatively! stable! industry!investment! in! R&D).! In! contrast,! when! the! competition! regime! is! relatively! fierce! (less!concentration! and!more! market!share! instability,! rising! industry!R&D! investment),! increasing!R&D!intensity!benefits!those!firms!with!growth!performance!at!the!median!level!or!above,!with!the! strongest! effect! found! for! high! growth! firms.! ! Furthermore,! during! periods! of! fierce!competition! high! growth! firms! that! invest! to! achieve! above!average! investment! in!R&D!also!appear! to!gain!growth!advantage.! ! 
# )( (#(,(")$$#'"!($#5(:?FF?;*#)()d!
                                                 
19 The absence of acquisitions pre-1980 is discussed in Section3.1.  
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hypothesis!that!variety!matters!more!in!periods!in!which!there!is!higher!intensity!of!innovation!and!dynamic!change.! In! times!of! strong!competition! firms!must!grow!or!die,!and!it!is!through!innovation!that!growth!occurs.!!!!We!believe! this! suggests! that!industrial!policy!must!be!clearly!linked!to!competition!policy!but!where!competition! is!understood!dynamically.! 
) ( *)!)$)')4'$,)'"(5,)$*)also!targeting! the!competitive!conditions!in!which!they!operate.!!!!!!
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!!!Where! ! is! an! index! for! the! ! firms,! and! j! the!observations! for!each! firm!and!)<J#K A #J* @
J# B KK,! is! the! piecewise! linear! quantile! loss! function! used! for! each! quantile! regression!as!described!by!Koenker!and!Bassett!(1978).!!!The! penalized! fixed! effect! estimator! produces! slope! coefficient! estimates! for! each! selected!quantile,! but! the! fixed! effect! for! each! firm!%4 ! are! independent!of!quantiles,! thereby!avoiding!estimating! fixed! effects! for! each! different! quantile! regression.! Estimation! is! performed! by!minimising!the!expression!selecting!$6!weights!for!each!of!the!!quantiles!which!control!for!the!influence! of! quantiles! on! the! estimation! of! %4 ! and! applying! a! penalty! term! to! penalise! the!vectors!of!fixed!effect!coefficients,!shrinking!these!coefficients!toward!zero.!The!importance!of!the!penalty!term!is!controlled!by!selecting!a!value!of!(!(Koenker,!2004).!We!set!( A !and!select!an! even! weighting! of! $6! across! quantiles.! Varying! the! choice! of! weights! made! only! minor!changes! to! the!reported!results.!For!a!detailed!discussion!of! this!method!see!Koenker! (2004).!Standard! errors! are! constructed! via! a! generalized! bootstrap! with! unit! exponential! weights!sampled!for!each!firm.!!For!comparison!we!also!report!regression!results!for!OLS!and!least!squares!(within)!fixed!effect!estimators! with! robust! errors! using! HuberYWhite!sandwich!estimators.!We!also! run!standard!quantile! regression! estimation! using! Koenker! and! Basset! (1978)! method,! but! preferring!bootstrapped!standard!errors!with!1000!repetitions!due!to!the!presence!of!heteroskadasticity.!!
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